|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||3.9000 - 3.9800|
|52-week range||3.9000 - 3.9800|
|Beta (5Y monthly)||1.76|
|PE ratio (TTM)||20.90|
|Earnings date||16 Feb 2022 - 21 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed...
OPKO Health's (OPK) BioReference Laboratories announces preparedness with respect to COVID-19 testing in the advent of the Omicron Variant.
OPKO Health's (OPK) third-quarter results benefit from strength in its Pharmaceuticals segment, backed by robust RAYALDEE sales.